Use of DBA/2N mice in models of systemic candidiasis and pulmonary and systemic aspergillosis

R F Hector1, E Yee, M S Collins

  • 1Cutter Biological, Berkeley, California 94710.

Insights

Mice lacking complement component 5 (C5) showed increased susceptibility to fungal infections like candidiasis and aspergillosis. These DBA/2N mice had significantly lower lethal doses, highlighting C5

Area of Science:

  • Immunology
  • Infectious Diseases
  • Mycology

Background:

  • Systemic candidiasis and aspergillosis are serious fungal infections.
  • Complement component 5 (C5) plays a crucial role in the immune response.
  • DBA/2N mice are genetically deficient in C5.

Purpose of the Study:

  • To establish and evaluate mouse models for systemic candidiasis and pulmonary/systemic aspergillosis.
  • To compare the lethality of these infections in C5-deficient DBA/2N mice versus normal outbred CFW mice.
  • To investigate the role of C5 in host defense against invasive fungal infections.

Main Methods:

  • Establishment of systemic candidiasis and pulmonary/systemic aspergillosis models in DBA/2N mice.
  • Comparison of 50% lethal dose (LD50) values between DBA/2N and CFW mice.
  • Intranasal infection with Aspergillus fumigatus in cortisone acetate-treated DBA/2N mice for pulmonary aspergillosis model.

Main Results:

  • DBA/2N mice exhibited 10- to 1,000-fold lower LD50 values compared to CFW mice across infection models.
  • Onset of death was slightly delayed in DBA/2N mice.
  • A single dose of cortisone acetate was sufficient to ensure lethality in the pulmonary aspergillosis model.

Conclusions:

  • C5 deficiency significantly increases susceptibility to systemic candidiasis and aspergillosis in mice.
  • DBA/2N mice serve as a valuable model for studying the role of C5 in fungal immunity.
  • These findings underscore the importance of the complement system in controlling invasive fungal infections.

Related Concept Videos